Facts of Diabetic Eye Disease: another American becomes legally blind from diabetic retinopathy every 30 minutes. There is no independent tracking of irreparable vision loss from other eye diseases commonly associated with diabetes (retinal vascular occlusion, AION, glaucoma)….
Read More »The Incretin Effect
For the complete article, The Incretin Effect, and information on other aspects of GLP-1 treatment, please visit Novo Nordisk’s diabetesinamerica at www.novomedlink.com/diabetes/diabetes-in-america.
Read More »Perspectives from Diabetes Thought Leaders on the Use of GLP-1 Agonists
Leading experts, Anne L. Peters, MD, Ralph A. DeFronzo, MD, Alan J. Garber, MD, PhD, Robert R. Henry, MD, Richard Bergenstal, MD, and others, share their thoughts on GLP-1 therapy….
Read More »New Vibe Insulin Pump with CGMS
New Vibe Insulin Pump with CGMS Animas’ Glucose-Monitoring Insulin Pump OK’d in Europe. Animas said it has received a CE Mark in Europe for its Animas Vibe product, which the company said is the first continuous glucose monitoring-enabled, waterproof insulin pump system for people with diabetes. The product is also the …
Read More »HbA1C Test Poorly Predictive in Dialysis Patients
Conventional glucose control monitoring methods may not be as meaningful in diabetes patients with end-stage renal disease, researchers found. Patients on dialysis will normally show a lower A1c than they actually have, giving patients and physicians a false sense of security.… The Gold standard long-term glucose monitoring test for patients …
Read More »New Polypill Data Predicts a Halving of CV Events
The first randomized, placebo-controlled study of a polypill has suggested that use of such a product in primary prevention could bring about a halving of heart disease and stroke events….
Read More »Carbohydrate Counting Improves Glycemic Control for Type 1s
Carbohydrate quantification is an effective and safe strategy to manage glycemia and improve QoL.…
Read More »High-Fat Diet During Pregnancy Programs Child for Future Diabetes
A high-fat diet during pregnancy may program a woman’s baby for future diabetes, even if she herself is not obese or diabetic.…
Read More »Possible New Treatment for Prediabetic Patients
A natural product called DLPC (dilauroyl phosphatidylcholine) increases sensitivity to insulin and reduces fatty liver.…
Read More »Mutations in the Skin Barrier Correlate with Increased Type 2 Diabetes Risk
Defective skin barrier function, as evidenced by common filaggrin mutations, may predispose patients to type 2 diabetes.…
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.